A study to demonstrate the efficacy of GSK Biologicals' influenza vaccine (Fluarix) administered intramuscularly in adults.

Trial Profile

A study to demonstrate the efficacy of GSK Biologicals' influenza vaccine (Fluarix) administered intramuscularly in adults.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza A virus infections; Influenza B virus infections; Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 15 Dec 2009 Results were published in the Journal of Infectious Diseases.
    • 25 Oct 2008 Primary endpoint 'vaccine protective efficacy' has been met.
    • 08 May 2008 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top